When side effects do occur, they are typically mild and dose-dependent
Patients starting GLP-1 therapy Patients adjusting doses Patients wanting to reduce side effects or progress Patients who love data or structure The Meds Supported medications Shotsy supports commonly prescribed GLP-1 treatments, including semaglutide and tirzepatide, in both injectable and oral forms, as well as brand-name and compounded options
6d) or MAR709 versus GIPR antagonism (Fig
The increases in their expression can impact AR in a variety of manners, including stabilization of AR mRNA through RNA-RNA hybridization (ARLNC1 [117]), absorption of miRNAs (plncRNA-1 [118]), facilitation of mRNA splicing (PRKAG2-AS1, HOXC-As1 [119]), interference with epigenetic control over AR target genes (SOCS2-AS1 [120]), preventing AR degradation (HOTAIR [121]), regulating its binding to chromatin (PCAT1 [122]) or binding to AR and thereby enhancing its transactivation (PCAT8, PCGEM1 [123])
Ruefli AA, Ausserlechner MJ, Bernhard D, Sutton VR, Tainton KM, Kofler R et al